Systematic review evaluating cardiovascular events of the 5-alpha reductase inhibitor - Dutasteride

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

(2012) Neil E Fleshner et al.   LANCET

Effect of Dutasteride on the Risk of Prostate Cancer

(2010) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study

(2009) Claus G. Roehrborn et al.   EUROPEAN UROLOGY

Efficacy and safety of dutasteride in Japanese men with benign prostatic hyperplasia

(2009) Taiji Tsukamoto et al.   INTERNATIONAL JOURNAL OF UROLOGY

Dutasteride

(2008) Susan J Keam et al.   DRUGS

The Influence of Baseline Parameters on Changes in International Prostate Symptom Score with Dutasteride, Tamsulosin, and Combination Therapy among Men with Symptomatic Benign Prostatic Hyperplasia and an Enlarged Prostate: 2-Year Data from the CombAT Study

(2008) Claus G. Roehrborn et al.   EUROPEAN UROLOGY

Effect of Dutasteride on Intraprostatic Androgen Levels in Men With Benign Prostatic Hyperplasia or Prostate Cancer

(2008) Roger Rittmaster et al.   UROLOGY